Navigation Links
Gentiva Reports First Quarter 2009 Results

- Reaffirms 2009 Performance Outlook -

MELVILLE, N.Y., April 30 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV), a leading provider of comprehensive home health services, today reported the following 2009 first quarter results:

  • Net revenues of $288.9 million for the quarter ended March 29, 2009 compared to $321.6 million, which included net revenues of $77.8 million from its CareCentrix business unit, for the quarter ended March 30, 2008. Excluding prior year's first quarter net revenues from CareCentrix, Gentiva's net revenues grew about $45 million, or 18% in the 2009 first quarter. The Company sold a majority interest in CareCentrix to Water Street Healthcare Partners on September 25, 2008.

  • Net income of $18.0 million, or $0.60 per diluted share, which included a non-recurring pre-tax net gain of $5.8 million or $0.19 per diluted share resulting from the 2009 first quarter sale of certain branch offices that specialized primarily in pediatric home health care services. These results compared to net income of $7.7 million or $0.27 per diluted share in the 2008 first quarter.

  • Excluding the net gain from the sale of the home health branch offices referred to above and special charges related to restructuring and integration activities, adjusted net income for the 2009 first quarter was $12.7 million, up 61% compared with the prior year period. On a diluted earnings per share basis, adjusted net income in the 2009 first quarter was $0.43, excluding special charges of $0.02 per diluted share, compared with $0.27 in the corresponding period of 2008.

  • A 19% increase in earnings before int SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Interest paid $3,117 $5,702 Income taxes paid $1,489 $417 (in 000's) Supplemental Information 1st Quarter ------------------------- ----------- 2009 2008 ---- ---- Segment Information (1) Net revenues Home Health $257,745 $217,000 CareCentrix - 77,848 All Other (5) 31,571 27,729 Intersegment revenues (399) (944) -------- -------- Total net revenues (5) $288,917 $321,633 ======== ======== Operating contribution (3) Home Health $43,225 $31,202 CareCentrix (4) - 6,326 All Other 3,230 2,845 ------- ------- Total operating contribution 46,455 40,373 Corporate expenses (18,215) (16,579) Gain on sale of business, net 5,832 - Depreciation and amortization (5,487) (5,151) Interest expense, net (2,391) (5,426) ------- ------- Income before income taxes $26,194 $13,217 ======= ======= 1st Quarter ----------- 2009 2008 ---- ---- Net Revenues by Major Payer Source: Medicare Home Health $186,070 $145,106 Other 20,057 16,200 -------- -------- Total Medicare 206,127 161,306 Medicaid and local government 28,142 31,566 Commercial Insurance and Other: Paid at episodic rates 16,130 11,146 Other 38,518 117,615 -------- -------- Total Commercial Insurance and Other 54,648 128,761 -------- -------- Total net revenues $288,917 $321,633 ======== ======== A reconciliation of EBITDA to Net income - As Reported amounts follows: (2) 1st Quarter ----------- 2009 2008 ---- ---- EBITDA (3) $28,240 $23,794 Gain on sale of business, net 5,832 - Depreciation and amortization (5,487) (5,151) Interest expense, net (2,391) (5,426) ------ ------ Income before income taxes 26,194 13,217 Income tax expense (6) (8,450) (5,494) ------ ------ Income before equity in net earnings of affiliate 17,744 7,723 Equity in net earnings of affiliate 278 - ------- ------ Net income - As Reported $18,022 $7,723 ======= ====== Notes: (1) The Company's senior management evaluates performance and allocates resources based on operating contributions of the operating segments, which exclude corporate expenses, depreciation, amortization, and interest expense (net), but include revenues and all other costs directly attributable to the specific segment. (2) EBITDA, a non-GAAP financial measure, is defined as income before interest expense (net of interest income), income taxes, depreciation and amortization. Management uses EBITDA to evaluate overall performance and compare current operating results with other companies in the healthcare industry. EBITDA should not be considered in isolation or as a substitute for net income, operating income or cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Because EBITDA is not a measure of financial performance under accounting principles generally accepted in the United States and is susceptible to varying calculations, it may not be comparable to similarly titled measures in other companies. (3) Operating contribution and EBITDA for the first quarter of 2009 and 2008 included special charges of $0.9 million and $0.3 million, respectively. The special charges, which included restructuring and integration costs and costs and professional fees associated with merger and acquisition activities, were reflected as follows for segment reporting (dollars in millions): 1st Quarter ----------- 2009 2008 ---- ---- Home Health $0.1 $0.1 Corporate expenses 0.8 0.2 ---- ---- Total $0.9 $0.3 ==== ==== (4) Operating contribution for CareCentrix, in which the Company sold a majority ownership interest on September 25, 2008, was comprised of the following (dollars in thousands): 1st Quarter ----------- 2009 2008 ---- ---- Gross profit $- $14,290 Selling, general and administrative expenses - (8,077) Add: depreciation - 113 -- ------ Operating contribution $- $6,326 == ====== (5) Certain reclassifications have been made to the 2008 first quarter statement of income and supplemental information to conform to the current year presentation. The primary impact of the reclassifications was to reduce (i) net revenues in All Other and (ii) cost of services and goods sold by approximately $2.1 million in the 2008 first quarter relating to the reimbursement of nursing home room and board charges for hospice patients. The Company believes that this presentation better conforms to industry practice. (6) The Company's effective tax rate was 32.3% for the first quarter of 2009, and 41.6% for the first quarter of 2008. During the first quarter of 2009, the Company recorded a pre-tax gain, net of transaction costs, of $5.8 million relating to the sale of several branch offices that specialized primarily in pediatric home health care services. There was no income tax expense relating to the gain on sale of business due to the utilization of a capital loss carryforward. Excluding the impact of the gain on sale of businesses, the Company's effective tax rate would have been 41.5% for the first quarter of 2009.

    Forward-Looking Statement

    Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions, including the ability to access capital markets; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters or terrorist acts; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 28, 2008.

             Financial and Investor Contact:  John R. Potapchuk
                                           or Brandon Ballew
             Media Contact:                   Jennifer Gery-Egan
                                              Brainerd Communicators

    erest, taxes, depreciation and amortization (EBITDA) to $28.2 million in the first quarter of 2009; EBITDA as a percentage of net revenues improved to 9.8% in the first quarter of 2009 versus 7.4% in the prior-year period. EBITDA included restructuring and integration costs of $0.9 million in the first quarter of 2009 as compared to $0.3 million for the prior year period.

"Gentiva is off to a good start to 2009, both financially and operationally," said Gentiva CEO Tony Strange. "Our results for the quarter were again led by our Home Health segment as we focus on meeting the needs of the nation's growing senior population, for which home healthcare is a cost-effective and patient-preferred solution. The aggregate results of our other businesses also showed improved performance in the quarter, primarily driven by growth in hospice. Based on these solid first quarter results and our confidence that the Company will continue to execute on its strategy during the remainder of the year, we are today reaffirming our revenue and earnings outlook for 2009."

Gentiva reported these segment highlights for the quarter:

  • Home Health's 19% revenue growth to $257.7 million and operating contribution growth of 39% to $43.2 million.

  • Revenues in Gentiva's All Other segment - which includes hospice, respiratory therapy and home medical equipment, infusion therapy and consulting - increased 14% to $31.6 million, while operating contribution increased 14% to $3.2 million compared to the prior-year period.

During the 2009 first quarter, Gentiva generated $25 million in operating cash flow, repaid $14 million of its term loan and spent $4.8 million to repurchase 327,828 shares of its common stock. At March 29, 2009, the Company reported cash and cash equivalents of $79.6 million and long-term debt of $237 million.

Full-Year 2009 Outlook

Gentiva also reaffirmed its outlook for fiscal 2009 of full-year net revenues in a range of $1.14 billion to $1.18 billion. On a diluted earnings per share basis, adjusted net income is expected to be in a range between $1.72 and $1.80, excluding restructuring and integration costs which are estimated to range from $3 million to $5 million for the year. Gentiva's 2009 outlook represents an increase in net revenues of 8% to 11% and an increase in diluted earnings per share of 20% to 30% when compared with 2008 pro forma financial results, which reflect the Company's performance as if the CareCentrix divestiture had occurred at the beginning of fiscal 2008. The 2009 outlook excludes the $0.19 per diluted share net gain resulting from the sale of branches specializing primarily in pediatric home health services in the first quarter.

Non-GAAP Financial Measures

The information provided in this press release includes certain non-GAAP financial measures as defined under Securities and Exchange Commission (SEC) rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those measures to the most directly comparable GAAP measures.

Conference Call and Web Cast Details

The Company will comment further on its first quarter 2009 results during its conference call and live web cast to be held Thursday, April 30, 2009 at 10:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call #94103101. The web cast is an audio-only, one-way event. Web cast listeners who wish to ask questions must participate in the conference call. Log onto to hear the web cast. A replay of the call will be available on April 30, beginning at approximately 1 p.m. ET, and will remain available continuously through May 7. To listen to a replay of the call from the United States, Canada or international locations, dial (800) 642-1687 or (706) 645-9291 and enter the following PIN at the prompt: 94103101. Visit to access the web cast archive. This press release is accessible at and a transcript of the conference call is expected to be available on the site within 48 hours after the call.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is a leading provider of comprehensive home health services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. For more information, visit Gentiva's web site,, and its investor relations section at GTIV-E

(tables and notes follow)

        (in 000's, except per share data)                      1st Quarter
                                                           2009          2008
                                                           ----          ----
    Statements of Income
        Net revenues                                   $288,917      $321,633
        Cost of services and goods sold                 140,809       185,110
                                                        -------       -------
        Gross profit                                    148,108       136,523
        Selling, general and administrative
         expenses                                     (125,355)     (117,880)
        Gain on sale of business, net                     5,832             -
        Interest expense                                (3,192)       (6,093)
        Interest income                                     801           667
                                                            ---           ---
        Income before income taxes                       26,194        13,217
        Income tax expense                                8,450         5,494
                                                          -----         -----
        Income before equity in net earnings of
         affiliate                                       17,744         7,723
        Equity in net earnings of affiliate                 278             -
                                                            ---           ---
        Net income                                      $18,022        $7,723
                                                        =======        ======

      Earnings per Share
        Net income:
           Basic                                          $0.62         $0.27
                                                          =====         =====
           Diluted                                        $0.60         $0.27
                                                          =====         =====

        Average shares outstanding:
           Basic                                         28,944        28,282
                                                         ======        ======
           Diluted                                       29,829        29,043
                                                         ======        ======

    Condensed Balance Sheets
      ASSETS                                       Mar 29, 2009  Dec 28, 2008
      ------                                       ------------  ------------
        Cash and cash equivalents                       $79,559       $69,201
        Short-term investments (A)                        2,550             -
        Accounts receivable, net (B)                    181,591       177,201
        Deferred tax assets                              13,363        11,933
        Prepaid expenses and other current
         assets                                          15,766        13,141
                                                        -------       -------
             Total current assets                       292,829       271,476

        Long-term investments (A)                         8,500        11,050
        Note receivable                                  25,000        25,000
        Investment in affiliate                          23,542        23,264
        Fixed assets, net                                65,159        63,815
        Intangible assets, net                          249,228       250,432
        Goodwill                                        308,155       308,213
        Other assets                                     20,290        20,247
                                                       --------      --------
            Total assets                               $992,703      $973,497
                                                       ========      ========

        Accounts payable                                 $6,433        $8,027
        Payroll and related taxes                        26,738        17,869
        Deferred revenue                                 38,407        32,976
        Medicare liabilities                              7,154         6,680
        Obligations under insurance programs             39,102        39,628
        Other accrued expenses                           39,533        40,895
                                                        -------       -------
             Total current liabilities                  157,367       146,075

        Long-term debt                                  237,000       251,000
        Deferred tax liabilities, net                    66,299        64,262
        Other liabilities                                17,071        17,189
        Shareholders' equity                            514,966       494,971
                                                       --------      --------
             Total liabilities and shareholders'
              equity                                   $992,703      $973,497
                                                       ========      ========

        Common shares outstanding                        28,803        28,864
                                                         ======        ======

    (A) Short-term and long-term investments consisted of AAA-rated auction
    rate securities.  Short-term investments were presented net of a valuation
    allowance of $0.4 million, the charge for which was recorded in
    interest expense in the 2009 first quarter.  At March 29, 2009 and
    December 28, 2008, long-term investments were presented net of a valuation
    allowance of $1.5 million and $1.9 million, respectively.

    (B) Accounts receivable, net, included an allowance for doubtful accounts
    of $7.5 million and $8.2 million at March 29, 2009 and December 28, 2008,

        (in 000's)                                           1st Quarter
    Condensed Statements of Cash Flows                      2009      2008
    ----------------------------------                      ----      ----
      Net income                                         $18,022    $7,723
      Adjustments to reconcile net income to net cash
       provided by operating activities:
        Depreciation and amortization                      5,487     5,151
        Amortization of debt issuance costs                  399       287
        Provision for doubtful accounts                    1,410     2,600
        Equity-based compensation expense                  1,805     1,736
        Windfall tax benefits associated with equity-
         based compensation                                 (547)   (1,235)
        Loss on sale of auction rate securities              450         -
        Gain on sale of business, net                     (5,832)        -
        Equity in net earnings of affiliate                 (278)        -
        Deferred income taxes                                427     4,848
      Changes in assets and liabilities, net of effects
       from acquisitions and dispositions:
        Accounts receivable                               (5,800)  (19,598)
        Prepaid expenses and other current assets         (2,565)   (2,151)
        Current liabilities                               11,976     8,825
      Other, net                                              42       (51)
                                                          ------     -----
      Net cash provided by operating activities           24,996     8,135
                                                          ------     -----

      Purchase of fixed assets                            (5,671)   (6,624)
      Proceeds from sale of business, net of cash
       transferred                                         5,619         -
      Acquisition of businesses, net of cash acquired          -   (47,405)
      Purchases of short-term investments available-
       for-sale                                                -   (28,000)
      Maturities of short-term investments available-
       for-sale                                                -    44,900
                                                             ---   -------
      Net cash used in investing activities                  (52)  (37,129)
                                                             ---   -------

      Proceeds from issuance of common stock               3,899     4,119
      Windfall tax benefits associated with equity-
       based compensation                                    547     1,235
      Borrowings under revolving credit facility               -    12,000
      Home Health Care Affiliates debt repayments              -    (7,420)
      Debt issuance costs                                      -      (432)
      Repayments under the Company's term loan           (14,000)        -
      Repurchases of common stock                         (4,813)        -
      Repayment of capital lease obligations                (219)     (307)
                                                         -------    ------
      Net cash (used in) provided by financing
       activities                                        (14,586)    9,195
                                                         -------   -------

      Net change in cash and cash equivalents             10,358   (19,799)
      Cash and cash equivalents at beginning of period    69,201    36,181
                                                         -------   -------
      Cash and cash equivalents at end of period         $79,559   $16,382
                                                         =======   =======

SOURCE Gentiva Health Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Gentiva(R) Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday, April 30, 2009
2. Gentiva(R) Health Services to Present at Upcoming Investor Conferences
3. Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches
4. Gentiva(R) Health Services Schedules Fourth Quarter and Fiscal 2008 Earnings Call and Web Cast for Wednesday, February 18, 2009
5. Gentiva(R) Health Services to Present January 13 at J.P. Morgan Healthcare Conference in San Francisco
6. Gentiva Health Services Confirms Management Succession
7. Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens
8. Gentiva Reports Third Quarter Revenue and Profit Growth
9. Gentiva Safe Strides(R) Home Balance Therapy Program is Reducing Risk of Dangerous Falls and Relieving Pain for Thousands of Older Americans
10. Gentiva(R) Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday, July 31, 2008
11. Gentiva(R) Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York
Post Your Comments:
(Date:10/9/2015)... ... , ... With the FCPX LUT Vibrance pack from Pixel Film Studios, editors ... Lookup Table that contains a mathematical formula for modifying an image. The LUT changes ... with 60 vibrant CUBE LUT files. , Inspired by many YouTube make-up ...
(Date:10/9/2015)... ... 09, 2015 , ... Dentist in Huntington Beach , ... that uses clear, plastic aligners. This alternative to braces has become wildly popular ... patients to complete treatment in privacy. Additionally, Invisalign aligners are removable, so patients ...
(Date:10/9/2015)... Stockton, CA (PRWEB) , ... October 09, 2015 ... ... year anniversary of their “Agents of Change” program, a community improvement initiative that ... The newest charity to benefit from the assistance of Confidence Plus Insurance is ...
(Date:10/9/2015)... ... October 09, 2015 , ... ViewPoint Center, a teen mental health hospital ... mental illness, the stigma associated with mental illness causes many to hide away in ... importance of supporting teens with mental illness , providing teens with comprehensive diagnostic ...
(Date:10/9/2015)... ... , ... Most people assume that Chinese food is more nutritious than American ... T’ai Chi Master and integrative medicine guru Steven Aung, MD agrees with that assessment, ... that they potentially complement one another, with each supplying nutritional elements the other may ...
Breaking Medicine News(10 mins):
... Sales and Marketing Veteran to Drive International Retail Expansion, ... Group and New WrinkleFree Brand Line ExtensionIRVINE, Calif., Jan. ... developer and distributor of medically developed and efficacy-based skin ... mass market retail locations throughout the U.S., announced today ...
... The following statement can be attributed to Michael ... has consistently said two things: We are not ... But we have urged public policy makers to ... merger without conditions, because without conditions the merger ...
... (Nasdaq: OMCL ), a leading provider of system solutions to acute healthcare ... quarter 2008 financial results. , What: Omnicell ... webcast, When: January ... Lipps, chairman, president and chief executive officer, ...
... Maine, Jan. 21 IDEXX Laboratories, Inc. (Nasdaq: ... quarter and full-year financial results for Friday, January 30, at ... conference call beginning at 9:00 a.m. (eastern) on that day. ... through a link on the IDEXX Web site, ...
... can lead to failure, , , WEDNESDAY, Jan. 21 (HealthDay ... a common cause of kidney transplant failure may help ... polyomavirus nephropathy, which affects about 9 percent of kidney ... adults but can cause serious problems for people with ...
... CAMBRIDGE, Mass. -- Schizophrenia may blur the boundary between ... that is involved in self-reflection, and thus causing an ... brain imaging study has found. , The traditional ... and emotions that characterize the disease are caused by ...
Cached Medicine News:
(Date:10/9/2015)... and CINCINNATI , Oct. 9, 2015 ... two Design Thinking labs with Konica Minolta Medical Imaging ... CFI to utilize Design Thinking to help healthcare providers ... future using a visual roadmap that they can customize ... --> Primary Imaging is the initial procedure, or ...
(Date:10/9/2015)... 9, 2015 India ... --> India along ... announces addition of 3 divalproex sodium market ... for global markets as well as individually for ... with analysis of major players. ...
(Date:10/9/2015)... , Oct. 9, 2015   Lexicon Pharmaceuticals, Inc. ... TELESTAR Phase 3 clinical study of telotristat etiprate has been ... annual symposium to be held from October 15-17, in ... with patients who completed the randomized treatment portion of the ... a poster session. --> --> ...
Breaking Medicine Technology:
... Minn., May 4, 2011 American Medical Systems® ... devices and therapies for male and female pelvic health, ... Ministry of Health, Labor and Welfare (MHLW) to market ... the treatment of Benign Prostatic Hyperplasia (BPH), or enlarged ...
... 4, 2011 The most recent release of Via ... decision support for advance care planning to encourage early ... treatment intent and likely outcomes. Recent ... effect that attention to planning end of life care ...
Cached Medicine Technology:
... 4 Dot with 955R Red/Green glasses ... presence of binocular vision. Consists of ... discs: two green, one red and ... any distance. Patient wears red/green glasses ...
20 foot distance 22-1/2" X 11-1/2". This test for illiterate patients has HOTV letters on one side and Allen figures on the other....
Angled 30 degree shaft. 13 mm from tip to bend with 2.5 mm hook curved tip. Polished finished. Overall length excluding hub: 35 mm, 1.4 inches....
McIntyre-Binkhorst, length 18 mm....
Medicine Products: